Wedbush Predicts Reduced Earnings for Edgewise Therapeutics
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Research analysts at Wedbush decreased their Q1 2025 earnings estimates for shares of Edgewise Therapeutics in a research note issued on Wednesday, April 2nd. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.40) for the quarter, down from their prior […]
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Research analysts at Wedbush decreased their Q1 2025 earnings estimates for shares of Edgewise Therapeutics in a research note issued on Wednesday, April 2nd. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.40) for the quarter, down from their prior […]
